Fig. 2From: Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapyDevelopment of iPSC-iNKT cells in mice. Differentiation of iPSCs of different origins into iNKT cells. Figures are adapted with permission from Watarai et al., J Clin Invest, 2010 [35], Copyright (2010) American Society for Clinical InvestigationBack to article page